In BV-2 cells, TWS119 at 2.5 μM for 60 min decreased glycogen synthase phosphorylation compared with DMSO. In primary neonatal mouse microglia exposed to LPS plus IFN-γ, TWS119 at 10 μM significantly attenuated the alteration in CD16 mRNA levels compared with LPS plus IFN-γ alone. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Glycogen synthase phosphorylation in microglial cells
Cell-based study · BV-2 cells [1]
BV-2 cells were exposed to TWS119 at 2.5 μM for 60 min. Treatment decreased glycogen synthase phosphorylation compared with DMSO.
Literature-Reported Treatment Conditions
- Treatment concentration
- 2.5 μM
- Exposure duration
- for 60 min
- Method
- exposed
- Vehicle
- DMSO
Methods and source locations
Compound reported in the paper: TWS119
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > GSK-3β inhibition decreases TNF-α production in LPS-stimulated microglia (S71, S72); Figure 1 legend (S170)
phosphorylation of glycogen synthase: phosphorylation of glycogen synthase; comparator: DMSO — Results > GSK-3β inhibition decreases TNF-α production in LPS-stimulated microglia (S71, S72)
Microglial inflammatory gene expression
Cell-based study · Primary microglia cells; cerebral cortex of neonatal C57BL/6 mice at P1–P2; n = 5 per group [2]
Primary microglia from neonatal mouse cerebral cortex received TWS119 at 10 μM immediately after LPS plus IFN-γ application. Treatment significantly attenuated the alteration in CD16 mRNA levels compared with LPS plus IFN-γ alone.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 μM
- Exposure duration
- immediately following the application of LPS plus IFN-γ; After 24 h of incubation
- Method
- added to the microglia cultures
- Co-treatment
- Other interventions in this design: lipopolysaccharide 100 ng/ml; interferon-γ 20 ng/ml. Compound effect isolated by the comparison: LPS+IFN-γ.
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: TWS119
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Methods > Primary microglia (S20, S26, S27, S29, S30); Results > TWS119 promoted pro-inflammatory to anti-inflammatory phenotype switch of microglia probably via the Wnt/β-catenin pathway in vitro (S158, S159); Fig. 7 legend (S209)
qRT-PCR; mRNA level of CD16: qRT-PCR; mRNA level of CD16; comparator: LPS+IFN-γ — Results > TWS119 promoted pro-inflammatory to anti-inflammatory phenotype switch of microglia probably via the Wnt/β-catenin pathway in vitro (S158, S159)